GPX-100 in Treating Patients With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: GPX-100
Sponsor: Gem Pharmaceuticals